Control of inflammatory process in patients with coronavirus affected by ZAX.1399.C03
Phase 2
Recruiting
- Conditions
- Incidence of inflammation due to the mechanism of COVID19.COVID-19U07.1
- Registration Number
- IRCT20210218050404N1
- Lead Sponsor
- Fasa University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
COVID-19 is detected by PCR laboratory diagnostic kit
Age over 18 years
Both sexes (male and female)
Having informed and written consent to participate in the study
No history of any allergies
No uncontrolled hypertension
Do not take anticoagulants (aspirin, Plavix, warfarin)
Not pregnant and breastfeeding
No diabetes in the person
Exclusion Criteria
Disagreement of the responsible physician of the patient before randomization
History of any allergies to drugs, various substances, food and ...
History of liver and kidney disease
Patient disagreement
Inability of the patient to take the drug for any reason
History of hypertension and heart disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method